Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 21923 | 343 | 26.9 | 37% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TYROSERLEUTIDE | Author keyword | 18 | 89% | 2% | 8 |
| 2 | BOVINE DIALYZABLE LEUKOCYTE EXTRACT | Author keyword | 14 | 100% | 2% | 7 |
| 3 | DIALYZABLE LEUKOCYTE EXTRACT | Author keyword | 12 | 86% | 2% | 6 |
| 4 | DIALYSABLE LEUCOCYTE EXTRACT | Author keyword | 8 | 100% | 1% | 5 |
| 5 | TRANSFER FACTOR | Author keyword | 6 | 14% | 11% | 39 |
| 6 | IMUNOR R | Author keyword | 6 | 100% | 1% | 4 |
| 7 | TYROSERVATIDE | Author keyword | 3 | 57% | 1% | 4 |
| 8 | YSL | Author keyword | 2 | 29% | 1% | 5 |
| 9 | INMUNOL VIROL | Address | 1 | 17% | 2% | 8 |
| 10 | IMMUNEPOTENT CRP | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TYROSERLEUTIDE | 18 | 89% | 2% | 8 | Search TYROSERLEUTIDE | Search TYROSERLEUTIDE |
| 2 | BOVINE DIALYZABLE LEUKOCYTE EXTRACT | 14 | 100% | 2% | 7 | Search BOVINE+DIALYZABLE+LEUKOCYTE+EXTRACT | Search BOVINE+DIALYZABLE+LEUKOCYTE+EXTRACT |
| 3 | DIALYZABLE LEUKOCYTE EXTRACT | 12 | 86% | 2% | 6 | Search DIALYZABLE+LEUKOCYTE+EXTRACT | Search DIALYZABLE+LEUKOCYTE+EXTRACT |
| 4 | DIALYSABLE LEUCOCYTE EXTRACT | 8 | 100% | 1% | 5 | Search DIALYSABLE+LEUCOCYTE+EXTRACT | Search DIALYSABLE+LEUCOCYTE+EXTRACT |
| 5 | TRANSFER FACTOR | 6 | 14% | 11% | 39 | Search TRANSFER+FACTOR | Search TRANSFER+FACTOR |
| 6 | IMUNOR R | 6 | 100% | 1% | 4 | Search IMUNOR+R | Search IMUNOR+R |
| 7 | TYROSERVATIDE | 3 | 57% | 1% | 4 | Search TYROSERVATIDE | Search TYROSERVATIDE |
| 8 | YSL | 2 | 29% | 1% | 5 | Search YSL | Search YSL |
| 9 | IMMUNEPOTENT CRP | 1 | 100% | 1% | 2 | Search IMMUNEPOTENT+CRP | Search IMMUNEPOTENT+CRP |
| 10 | SPECIFIC TRANSFER FACTOR | 1 | 100% | 1% | 2 | Search SPECIFIC+TRANSFER+FACTOR | Search SPECIFIC+TRANSFER+FACTOR |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MURINE TRANSFER FACTOR | 15 | 88% | 2% | 7 |
| 2 | DLE | 4 | 75% | 1% | 3 |
| 3 | DIALYZABLE LEUKOCYTE EXTRACT | 3 | 100% | 1% | 3 |
| 4 | TRANSFER FACTOR THERAPY | 3 | 100% | 1% | 3 |
| 5 | YSL | 3 | 100% | 1% | 3 |
| 6 | HUMAN HEPATOCARCINOMA | 2 | 43% | 1% | 3 |
| 7 | HUMAN HEPATOCARCINOMA BEL 7402 | 1 | 100% | 1% | 2 |
| 8 | IMREG 1 | 1 | 100% | 1% | 2 |
| 9 | LONG SURVIVORS | 1 | 100% | 1% | 2 |
| 10 | UPLE | 1 | 100% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Transfer Factor: an Overlooked Potential for the Prevention and Treatment of Infectious Diseases | 2013 | 5 | 58 | 52% |
| TRANSFER-FACTOR - PAST, PRESENT AND FUTURE | 1989 | 20 | 30 | 60% |
| Transfer factors in medical therapy | 2011 | 1 | 17 | 59% |
| TRANSFER-FACTOR - AN UPDATE | 1985 | 6 | 6 | 83% |
| CLINICAL USE OF TRANSFER-FACTOR - 25 YEARS ON | 1983 | 0 | 11 | 73% |
| A strategic approach to vaccine development: animal models, monitoring vaccine efficacy, formulation and delivery | 2002 | 15 | 28 | 4% |
| Inactivated whole-cell bacterial vaccines: current status and novel strategies | 1998 | 9 | 130 | 2% |
| IMMUNOLOGY OF CHORIORETINAL DISORDERS | 1981 | 12 | 13 | 8% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INMUNOL VIROL | 1 | 17% | 2.3% | 8 |
| 2 | UNIDAD DESARROLLO INVEST BIOPROC UDIBI | 1 | 100% | 0.6% | 2 |
| 3 | UNIDAD INVEST DESARROLLO INNOVAC MED BIOTECNO | 1 | 100% | 0.6% | 2 |
| 4 | BIOL SCI ENCB | 1 | 33% | 0.6% | 2 |
| 5 | OPERAT UNIT ORTHOPED | 1 | 50% | 0.3% | 1 |
| 6 | TEACHING HOSP TIANJIN 1 | 1 | 50% | 0.3% | 1 |
| 7 | RIJNLAND WOUND CLIN | 0 | 33% | 0.3% | 1 |
| 8 | IMMUNO MICROENVIRONM DIS | 0 | 12% | 0.6% | 2 |
| 9 | TRANSPLANTAT IMMUNOL BLOOD TRANSFUS | 0 | 20% | 0.3% | 1 |
| 10 | OPERAT UNIT RADIOTHER Y | 0 | 11% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000108682 | ST 789//HYPOXANTHINE DERIVATIVES//METHYL INOSINE MONOPHOSPHATE |
| 2 | 0.0000107530 | COCUK NOROLOJISI BD//IMMUNOGLOBLIN//ALBUMIN DISTRIBUTION |
| 3 | 0.0000078270 | LEWIS LUNG TUMOR//NONLINEAR MIXED EFFECT MODELING NONMEM//LEUKOCYTE ADHERENCE INHIBITION ASSAY |
| 4 | 0.0000076454 | POLLENOSES//TREATMENT OF CHILDREN//GASTRODUODENAL ZONE |
| 5 | 0.0000067143 | CYCLE OF EROSION//NEO LAMARCKIANISM//SEELEY |
| 6 | 0.0000057861 | DERIVATIZED BEADS//ADHESION MODELING//ANTI INFECTIVITY |
| 7 | 0.0000054407 | PROTEINS AND LIPIDS//ARBEITSGRP HEIMTIERE EXOT TIERE WILDTIERE//L TRYPTOPHAN METHYL ESTER |
| 8 | 0.0000052456 | HEMAL NODE//HEMAL NODES//AFFERENT LYMPHATICS |
| 9 | 0.0000050377 | BURP DOMAIN//RD22//BURP DOMAIN CONTAINING PROTEIN |
| 10 | 0.0000049790 | ENGN ENZYMOL//CYTOTOXIC RIBONUCLEASES//SURGICAL INFLAMMATION |